VITA 34 AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
13,554.00
13,786.00
14,169.00
16,290.00
19,186.00
20,409
Cost of Goods Sold (COGS) incl. D&A
5,843.00
6,209.00
8,005.00
7,944.00
8,882.00
8,435
Gross Income
7,711.00
7,577.00
6,164.00
8,346.00
10,304.00
11,974
SG&A Expense
7,500.00
7,217.00
8,760.00
9,021.00
10,125.00
-
EBIT
106.00
1,188.00
1,895.00
108.00
179.00
2,631
Unusual Expense
-
238.00
-
5.00
5.00
-
Non Operating Income/Expense
1,363.00
264.00
3,508.00
646.00
30.00
-
Interest Expense
205.00
96.00
126.00
121.00
200.00
800
Pretax Income
1,343.00
1,697.00
1,587.00
729.00
13.00
-
Income Tax
555.00
707.00
115.00
70.00
171.00
-
Equity in Affiliates
-
-
-
42.00
140.00
-
Consolidated Net Income
788.00
990.00
1,702.00
617.00
324.00
832
Net Income
838.00
1,100.00
1,979.00
408.00
322.00
832
Net Income After Extraordinaries
838.00
1,100.00
1,979.00
408.00
322.00
832
Net Income Available to Common
838.00
1,100.00
1,979.00
408.00
322.00
832
EPS (Basic)
0.27
0.35
0.65
0.14
0.09
0.20
Basic Shares Outstanding
3,112.70
3,112.70
3,039.70
3,049.00
3,549.50
-
EPS (Diluted)
0.27
0.35
0.65
0.13
0.09
-
Diluted Shares Outstanding
3,112.70
3,112.70
3,039.70
3,049.00
3,549.50
-
EBITDA
1,295.00
2,273.00
387.00
1,621.00
1,886.00
-
Other Operating Expense
105.00
828.00
701.00
783.00
-
9,343
Non-Operating Interest Income
79.00
103.00
100.00
91.00
33.00
-
Minority Interest Expense
50.00
110.00
277.00
209.00
2.00
-

About VITA 34

View Profile
Address
Deutscher Platz 5a
Leipzig Sachsen (Saxony) 04103
Germany
Employees -
Website http://www.vita34.de
Updated 07/08/2019
Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells. It operates through Stem Cell Banking segment. The Stem Cell Banking segment collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes.